Affirm Holdings Insider Sold Shares Worth $6,907,072, According to a Recent SEC Filing-March 2024-www.financetom.com

Affirm Holdings Insider Sold Shares Worth $6,907,072, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Affirm Holdings Insider Sold Shares Worth $6,907,072, According to a Recent SEC Filing

Nov 21, 2024 6:23 PM

03:15 AM EST, 11/21/2024 (MT Newswires) -- Libor Michalek, Director, President, on November 18, 2024, sold 111,048 shares in Affirm Holdings ( AFRM ) for $6,907,072. Following the Form 4 filing with the SEC, Michalek has control over a total of 159,449 shares of the company, with 159,449 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1820953/000162828024048722/xslF345X05/wk-form4_1732143783.xml

Previous page： KKR Raises $4.6 Billion for New Mid-Cap Fund Next page： Ideaya Biosciences Says Phase 2 Darovasertib Trial Showed 'Clinically Meaningful' Results

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

KKR Raises $4.6 Billion for New Mid-Cap Fund

Mar 10, 2026

07:31 AM EDT, 09/23/2024 (MT Newswires) -- KKR (KKR) said Monday it raised $4.6 billion for its new Ascendant Fund focused on mid-cap North American companies. The fund was oversubscribed and closed at its hard cap, the company said. It received backing from investors that include public pensions, family offices, and insurance companies, KKR added. Pete Stavros and Nate Taylor,...

Ideaya Biosciences Says Phase 2 Darovasertib Trial Showed 'Clinically Meaningful' Results

Mar 10, 2026

07:35 AM EDT, 09/23/2024 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said Monday that a phase 2 trial evaluating investigational drug darovasertib for treating neoadjuvant uveal melanoma showed interim results that were clinically meaningful. About 49% of the study's patients exhibited more than 30% tumor shrinkage in diameters and showed around 61% eye preservation rate. Ideaya said it completed...

Zeta Partners With OpenAI Over Athena Superintelligent Agent

Mar 10, 2026

04:01 AM EST, 01/06/2026 (MT Newswires) -- Zeta Global ( ZETA ) said late Monday it partnered with Microsoft ( MSFT )-backed (MSFT) OpenAI, under which the latter will support Athena's next phase of development. Financial terms weren't disclosed. Athena is Zeta's superintelligent agent for enterprise marketing, the company said, adding that it also introduced a beta version to Athena,...

Centerra Gold Invests in Headwater Gold

Mar 10, 2026

07:37 AM EDT, 09/09/2024 (MT Newswires) -- Centerra Gold ( CGAU ) signed a deal to acquire a 9.9% stake in Headwater Gold, equivalent to 7 million common shares, for about $1.5 million Canadian dollars ($1.1 million), Headwater said Monday. The agreement prices the investment at CA$0.22 apiece, according to Headwater. Headwater said it plans to use the proceeds for...